pillbase.ru

Male Balance Liquescence 3034

Active substance: PYGEUM, SAW PALMETTO, SMILAX ORNATA ROOT, ZINC, PRASTERONE, SUS SCROFA ADRENAL GLAND, BOS TAURUS TESTICLE, BOS TAURUS PROSTATE GLAND, SELENIUM, SILVER NITRATE, BOS TAURUS PITUITARY GLAND, POSTERIOR, BARIUM CARBONATE, CHIMAPHILA UMBELLATA WHOLE, CONIUM MACULATUM FLOWERING TOP, LYCOPODIUM CLAVATUM SPORE, GONORRHEAL URETHRAL SECRETION HUMAN

LIQUID · PYGEUM 1 [hp_X]/118mL, SAW PALMETTO 1 [hp_X]/118mL, SMILAX ORNATA ROOT 1 [hp_X]/118mL, ZINC 3 [hp_X]/118mL, PRASTERONE 4 [hp_X]/118mL, SUS SCROFA ADRENAL GLAND 6 [hp_X]/118mL, BOS TAURUS TESTICLE 6 [hp_X]/118mL, BOS TAURUS PROSTATE GLAND 6 [hp_X]/118mL, SELENIUM 6 [hp_X]/118mL, SILVER NITRATE 6 [hp_X]/118mL, BOS TAURUS PITUITARY GLAND, POSTERIOR 6 [hp_X]/118mL, BARIUM CARBONATE 12 [hp_X]/118mL, CHIMAPHILA UMBELLATA WHOLE 12 [hp_X]/118mL, CONIUM MACULATUM FLOWERING TOP 12 [hp_X]/118mL, LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/118mL, GONORRHEAL URETHRAL SECRETION HUMAN 30 [hp_X]/118mL

United StatesActive

Marketing holder: Professional Complementary Health Formulas

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
  • PYGEUM · 1 [hp_X]/118mL
  • SAW PALMETTO · 1 [hp_X]/118mL
  • SMILAX ORNATA ROOT · 1 [hp_X]/118mL
  • ZINC · 3 [hp_X]/118mL
  • PRASTERONE · 4 [hp_X]/118mL
  • SUS SCROFA ADRENAL GLAND · 6 [hp_X]/118mL
  • BOS TAURUS TESTICLE · 6 [hp_X]/118mL
  • BOS TAURUS PROSTATE GLAND · 6 [hp_X]/118mL
  • SELENIUM · 6 [hp_X]/118mL
  • SILVER NITRATE · 6 [hp_X]/118mL
  • BOS TAURUS PITUITARY GLAND, POSTERIOR · 6 [hp_X]/118mL
  • BARIUM CARBONATE · 12 [hp_X]/118mL
  • CHIMAPHILA UMBELLATA WHOLE · 12 [hp_X]/118mL
  • CONIUM MACULATUM FLOWERING TOP · 12 [hp_X]/118mL
  • LYCOPODIUM CLAVATUM SPORE · 12 [hp_X]/118mL
  • GONORRHEAL URETHRAL SECRETION HUMAN · 30 [hp_X]/118mL
Products containing zinc in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 2
  • Арепливир® Цинк
    таблетки, покрытые пленочной оболочкой, 200 мг+10 мг (original in Russian, GRLS)
    ЛП-№(012645)-(РГ-RU)
    Общество с ограниченной ответственностью "ПРОМОМЕД РУС" (ООО "ПРОМОМЕД РУС")
  • Арепливир® Цинк
    таблетки, покрытые пленочной оболочкой, 200 мг+10 мг (original in Russian, GRLS)
    ЛП-008815
    Общество с ограниченной ответственностью "ПРОМОМЕД РУС" (ООО "ПРОМОМЕД РУС")
EU 1
  • Wilzin
    zinc
    EMEA/H/C/000535
    Recordati Rare Diseases
Registration
Registration number
63083-3034
Registration status
Active
Dispensing
Over the counter
Route
ORAL
Sources
  • product · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.4 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.5 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.6 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.7 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.8 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.9 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.10 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.11 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.12 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.13 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.14 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source
  • ingredients.15 · openFDA NDC · 63083-3034 · Verified 2026-10-09 · open in source